Abstract: Hearing loss is a common disorder and can be conductive, sensorineural or mixed types. It can be congenital or acquired. In pediatric population more than 50% of deafness is genetic in origin. The patients may present as Deaf, mute or hard of hearing. Literature review was carried out on the pathophysiology including genetics, clinical presentation, etiology, diagnosis and various management, using internet Google, search PubMed. Additional information was obtained by cross referencing, using text and journals in the medical libraries.
Introduction
Deaf and dumb" or even "dumb‖ is an archaic term that is offensive, especially when referred to deaf people who do not speak. Many Deaf people do not use a spoken language, thus they are "mute". The word "dumb" means "mute". Deaf and Dumb Definition (www.nchearingloss.org/dumb.htm). Hearing loss is a very common congenital disorder with about 1.86 affected in every 1,000 newborns in US (Morton et al., 2006) , and affecting 4% of people aged younger than 45 years (Estivill et al.,1998) . In general, the type of hearing loss is classified as conductive, sensorineural, or mixed and either stable or progressive. In the pediatric population in US, more than 50% of patients with deafness have a genetic origin. (Morton et al., 2006) , with autosomal dominant, autosomal recessive, X-linked, or mitochondrial patterns of inheritance .In US less than 5% of deaf children have a deaf parent (Mitchell et al., 2004) . Etiologically it is classified into genetic (hereditary) or non-genetic (environmental) causes (Smith et al., 2005) . The time of onset in sensorineural hearing loss, is again classified as either congenital or acquired (or late-onset).
Deafness pathophysiology
Deafness can be from a mutation in a single gene or combination of mutations in different genes (Hildebrand et al., 2008) . Hereditary hearing loss and deafness may be conductive, sensorineural, or a combination of both, or syndromic or nonsyndromic. Syndromic with malformations of the external ear or other organs or, nonsyndromic which is not associated with abnormalities of the external ear or other medical problems. It can
Causes of deafness
These can be classified into, pre-natal and post-natal. Pre-Natal -A small percentage is due, to malformation of some portion of the auditory apparatus, while in others due to intermarriage of blood relations. Apart from inbreeding, some families have genetic background resulting in deafness. A chromosomal aberration can also produce deafness with or without a hereditary factor (Edwards, 1997) . 9.7% of infants have bilateral hearing loss, especially in infants who survived despite very low birth weight which is less than or equal to 1500 gm (Bergman et al., 1985) . In young children with autism, a delayed speech probably because of hearing loss, can be seen (Hilgert et al., 2009) . Prenatal infections from "TORCH" organisms (i.e., toxoplasmosis, rubella, cytomegalo virus, and herpes), can also give rise to acquired hearing loss in children. For postnatal infections, especially bacterial meningitis caused by Neisseria meningitidis, Haemophilus influenzae, or Streptococcus pneumoniae, and meningitis from other organisms, eg Escherichia coli, Listeria monocytogenes, Streptococcus agalactiae, and Enterobacter cloacae, can cause hearing loss, so as acoustic or cerebral trauma affecting the cochlea (Hildebrand et al.,2008) .
In developed countries, serous otitis media is the most common cause of hearing loss in children, affecting up to two thirds of preschool children. In addition, 1.0-2.0/1000 children have bilateral SNHL of at least 50 dB. In developed countries, SNHL appears to occur almost twice as often, and mainly due to infection (Davidson et al., 1989) . In underdeveloped countries, suppurative otitis media is common. Acquired hearing loss in adults is most often caused by environmental factors but mainly due to environmental-genetic interactions. Age-related and noiseinduced hearing losses are the most frequent examples of complex ‗environmental-genetic' hearing loss; but, up till now only a few genes have been associated with these complex traits (Konings et al., 2009) . Aminoglycoside-induced hearing loss is more common in persons with an A-to-G transition at nucleotide position 1555 in the mitochondrial genome (mtDNA) (Nance, 2003) . The aminoglycoside hypersensitivity is often maternally transmitted, and it suggests mitochondrial involvement (Hildebrand et al., 2008) . Because of the recent reduction in above infections, due to various treatments, the most common causes of bilateral SNHL are unknown (37.7%), genetic non-syndromic (29.2%), prenatal (12%), perinatal (9.6%), postnatal (8.2%), and genetic syndromic (3.2%) (Morzaria et al., 2004) , and studies confirm that autosomal recessive genes are responsible for most cases of unknown etiology. Most of the non-syndromic recessive gene mutations produce congenital profound deafness, of more than 90 dB hearing loss.
The genetics of deafness
All genetic diseases are due to aberrations in the coding function or the processing of human DNA. Different patterns of inheritance may give a single gene disorder, but it depends on whether the gene is autosomal (chromosomal pair 1-22) or sex chromosomal (X & Y) in its location or whether the gene is dorminant or recessive, and these patterns of inheritance are usually identifiable from the family tree. Alleles are alternative forms of the gene and it may or may not interfere with the function of the gene. If both alleles of the pair are the same, at that gene locus, then the individual is called homozygous, and if two different allele forms of the gene exist within the pair, then the individual is heterozygous. When a gene is expressed (i.e. apparent in the phenotype) in the heterozygous state, that allele is known as dorminant. If an allele undergoes a disease causing dominant mutation, the individual will show the disease even thou there is a normal allele present at the same locus on the paired chromosome. Autosomal recessive disorder requires that, the individual must have disease causing mutations on both maternal and paternal alleles before the disease manifest clinically. The recurrence risk in these patients in future pregnancies is 25%, and more frequently seen in persons with high consanguinity. Mygge (1879) reported 7.6% of pupils at Royal School for the deaf-mute had consanguineous parents and Lindenov (1945) reported 9.7%. According to Mendels law, recessive traits often manifest themselves in families where intermarriage has occurred, as the gene concerned is likely to be transmitted by both parents (Johnsen, 1952) . If there is successive consanguinity, the disorder may appear in generations, and the phenomenon is known as pseudominance. There are a large number of genes that can cause deafness. More than half of all genetic cases in some of the populations are due to recessive mutations at a single locus, GJB2 (gene gap junction protein beta2) or Connexin 26. Especially in countries close to Mediterranean the most common mutation for sensorineural deafness, is in mutation of 35delG an allele of GJB2 (Estivill et al.,1998; Cryns et al., 2004) and about 4% carrier rates are seen in some ethnic groups (Griffith et al., 2000) .
Prevalence
The most common birth defect in developed countries is hearing loss especially the sensorineural (Hilgert et al., 2009) . One in 500 new borns has bilateral permanent sensorineural hearing loss ≥40 dB; and by adolescence, it becomes to 3.5 per 1000 (Morton et al., 2006; Konings et al., 2009) . In US congenital SNHL occurs about three times more common than Down's syndrome (Gorlin et al., 1995) . A small percentage of prelingual deafness is syndromic associated with other disorders, such as kidney, heart or vision abnormalities or may be nonsyndromic autosomal dominant. More than 50% of prelingual deafness is genetic, autosomal recessive and nonsyndromic. And 50% of autosomal recessive nonsyndromic hearing loss can be due to the disorder DFNB1 (Arnos, 2003; Smith et al., 2002) on chromosome 13 caused by mutation of GJB2 that encodes the protein connexin 26 and GJB6 that encodes the protein connexin 30 (Nance, 2003) . Connexins are a class of membrane proteins that form hexameric connexions which form gap-junction channels with similar connexons of adjacent cells for exchange of electrolytes and metabolites. The carrier rate in the general population for a recessive deafness causing GJB2 variant is about 2.8 % (Kelley et al., 1998) .
Heritable causes. Single gene disorders
In syndromic hearing impairment it is in association with external ear or other organ malformations or with medical problems in other organs. Nonsyndromic hearing impairment has normal external ears and no related medical problems, but, may be associated with middle and inner ear abnormalities (Smith et al., 2002) .
Syndromic hearing impairment
Of the more than 400 syndromes in which HL is a feature, with 30% having prelingual deafness (Smith et al., 2002) .the most common are, Usher syndrome, Pendred syndrome and Jervell and Lange-Nielsen syndrome (Hilgert et al., 2009) .
(1)Autosomal dominant syndromic hearing impairment, egs, are-Waardenburg syndrome (WS), Branchiootorenal syndrome (BOR), Neurofibromatosis 2.
(2) Autosomal recessive syndromic hearing impairment, egs, are -Usher syndrome ,Biotinidase deficiency, and Pendred syndrome which is the second most common type of autosomal recessive syndromic hearing loss , where mutations, with enlarged vestibular aqueduct (EVA), are the most common form of inner ear abnormality (Middleton et al., 1998) . (3) For X-linked syndromic hearing impairment eg. Alport syndrome (4) Mitochondrial syndromic hearing impairment, eg. Keane-Sayre syndrome, and in association with Diabetes mellitus, Parkinson, Alzheimers disease.
Non-syndromic hearing impairment
To date, 46 genes have been identified as causing nonsyndromic HL (Hilgert et al., 2009) . The different gene loci for nonsyndromic deafness are designated DFN (for DeaFNess), where Loci are named based on mode of inheritance as- DFNA: Autosomal dominant  DFNB: Autosomal recessive  DFNX: X-linked Within the prelingual nonsyndromic hearing loss group, inheritance is 75%-80% autosomal recessive, 20%-25%autosomal dominant, and post lingual (Camp et al.,1997) and 1%-1.5% X-linked Most autosomal recessive loci cause prelingual severe-to-profound hearing loss. An exception is DFNB8, in which there is postlingual hearing impairment and is progressive. Most of the autosomal dominant loci cause postlingual hearing impairment, before the age of 20 years.
For X-linked nonsyndromic hearing loss it can be either pre-or postlingual.
(1)Autosomal dominant nonsyndromic hearing impairment  For the majority of cases, autosomal dominant nonsyndromic hearing loss does not have an identifiable single gene which is responsible for deafness. (Smith et al., 2014) . Persons with DFNA3 is characterized by progressive, moderate-to-severe sensorineural impairment. It is less commonly caused by heterozygous pathogenic variants in GJB6 (Smith et al., 2016) . The affected persons in these families develop normal speech and retains partial hearing. Thus they seldom integrate into the deaf community and usually marry normal hearing person (Camp et al., 1997) . Audioprofiling can be used for prognosis and measure the rate of hearing loss per year in individuals with nonsyndromic , autosomal dominant hearing loss of known cause (Hildebrand et al., 2008) . As audioprofile can be distinctive, it can be used to evaluate molecular genetic testing (Hildebrand et al., 2008) .
(2) Autosomal recessive nonsyndromic hearing impairment (ARNSD) deafness In the world, 50% of persons with autosomal recessive nonsyndromic hearing loss have deafnesscausing variants in GJB2 and mutations in the GJB2 gene at the DFNB1 locus (Castillo et al., 2002; Petersen et al., 2006) .Thus it should facilitate diagnosis as well as counselling for the most common genetic form of deafness. It is the most common cause of inherited hearing loss (Castillo et al., 2002) , and it is usually associated with retaining of low frequency tone, as degeneration starts from base and towards the apex later, where these low tone are felt. (Gorlin et al., 1995 )  These mutations in GJB2 cause severe or profound deafness (Smith et al., 2016) .
 Usually associated medical findings are absent (Smith et al., 2016) . Deafness is stable and nonprogressive, but progression has been reported in some cases. Onset is nearly always pre-lingual (Castillo et al., 2002; Pandya et al., 2003) but may not be congenital, and hearing may be normal at birth but progress rapidly in the first few months of life (Smith et al., 2016) .  Thus babies with mutations in GJB2 may pass new-born hearing screening but found to be profoundly deaf during infancy (Smith et al., 2016 ) (3) X-linked nonsyndromic hearing impairment  DFNX3 has a mixed conductive-sensorineural hearing loss, and is due to stapedial fixation (Camp et al.,1997 ) (4) Nonsyndromic hearing loss and deafness, mitochondrial
One variant in this gene, 1555G>A, is a frequent cause of maternally inherited nonsyndromic hearing loss (Camp et al., 1997) and some individuals will have hearing loss which is caused by aminoglycosides. 1% of the children will have mitochondrial mutations with prelingual deafness, but may be more frequent at a later age (Green et al., 1999; Hildebrand et al., 2008) . A Person, whose family tree (pedigree) you make is called proband, and the sisters and brothers of this person are called sibships.
(1) Risk to family members-Autosomal dominant hereditary hearing loss.
 Most of the individuals diagnosed as having Autosomal dominant hereditary hearing loss will have a deaf parent, and the family history is rarely negative (Gorlin et al., 1995; Smith et al., 2014) .  A proband with autosomal dominant hereditary hearing loss may also have the disorder as the result of a de novo deafness-causing variant, but the number is usually small (Gorlin et al., 1995) . Individuals diagnosed with autosomal dominant hereditary hearing loss will have a deaf parent, but the family history may not be there , due to failure to recognize hereditary hearing loss in family members, or late onset in a parent, reduced penetrance of the deafness-causing allele in an asymptomatic parent, or a de novo variant for hereditary hearing loss (Hilgert et al., 2009) .
 There is 50% chance of transmitting the mutated allele to each child in individuals with autosomal dominant hereditary hearing loss (Gorlin et al., 1995) . Usually both sexes are equally affected.and transmitted from generation to generation with no skip.  The offspring of a deaf person and a hearing person have a 10% empiric risk of deafness.
(2) Risk to family members -Autosomal recessive hereditary hearing loss  Both the parents are phenotypically normal but are heterozygous carriers with abnormal genes (Gorlin et al., 1995) and therefore carry a single copy of a deafness-causing variant GJB2.  Heterozygotes are asymptomatic (Smith et al., 2016) .  At conception, each sib has a 25% chance of being deaf, a 50% chance of having normal hearing and becoming a carrier, and a 25% chance of having normal hearing but not being a carrier (Smith et al., 2016) .  If at risk sib have normal hearing, the risk of his/her being a carrier is 2/3, like their parents with both sexes having equal chance of being affected ( Gorlin et al., 1995) . Offspring of a proband are obligate carriers. Again, each of the parents' siblings is at 50% risk for being carrier (Smith et al., 2002) . When the hearing sibling who is a carrier of aGJB2 deafness-causing mutation, marries a person with GJB2-related deafness, the chance of having a deaf child is about 50% (Smith et al., 2002) , and if both parents have GJB2-related deafness, the risk to their offspring is 100% (Smith et al., 2002) . (3) X-linked hereditary hearing loss For the offspring of a proband, males with X-linked hereditary hearing loss will pass the deafness-causing variant to all of their daughters and none of their sons (Gorlin et al., 1995) . (4) Mitochondrial disorders with hearing loss  All offspring of females with a mtDNA pathogenic variant are at risk of inheriting the variant (Hu et al., 1991) .  But the offspring of males with a mtDNA pathogenic variant are not at risk ( Gorlin et al., 1995) .  Mutations in the mitochondrial genome are only inherited through the maternal line and are never transmitted by the father.  Thus, mitochondrial inheritance can be considered in multigeneration families, and a history of exposure to aminoglycoside antibiotics.
Genetic counseling
Accurate genetic diagnosis can help in genetic counseling and risk assessment . As it is also important for the families and individuals to make informed choices regarding the use of genetic testing, there should be genetic counselling by skilled geneticists (Arnos, 2003) . Genetic counseling will provide individuals and families with information on the nature, heriditary, and implications of genetic disorders so, to help them make informed medical and personal decisions, know genetic risk and make clear the genetic status for family members. Many deaf people are more interested in obtaining information about the cause of their own deafness, and information on medical, educational, and social services, rather than information on prevention, reproduction, or family planning (Smith et al., 2016) . As in all genetic counseling, it is important for the counselor to acknowledge, identify, and respect the individual and family's concerns, and fears (Middleton et al., 1998; Arnos, 2003) . Just as a normal-hearing couple might wish to have a normal-hearing child, a deaf couple will also wish to have a deaf child (Smith et al., 2002) . The subsequent offspring of a hearing couple with one deaf child and an otherwise negative family history of deafness have an 18% (range, 15.0%-20.4%) empiric probability of deafness in future children (Green et al., 1999) .  If the deaf child does not have DFNB1 based on molecular genetic testing of GJB2 and GJB6, the recurrence risk is 14% for deafness unrelated to connexin 26 (Smith et al., 2014) .  If the hearing couple is consanguineous, the subsequent offspring have close to a 25% probability of deafness because of the high likelihood of autosomal recessive inheritance (Smith et al., 2014) .  The offspring of a deaf person and a hearing person have a 10% empiric risk of deafness (Green et al., 1999; Smith et al., 2014) .
Family planning
 Testing before pregnancy is the optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing (Smith et al., 2016) .  Advances in genetics and genomics will give technologies for prenatal diagnosis and gene therapy for hearing loss as well as other communication disorders which are genetically based (Amos, 2008) .  It is also better to offer genetic counseling and risks to offspring and reproductive options, to young adults who are deaf.  Thus, even before they are pregnant, genetics can provide knowledge to the deaf couples to know whether their children will be hearing or deaf (Nance, 2003) .
Diagnosis
Congenital hearing loss can be identified by newborn hearing screening (NBHS) (Hilgert et al., 2009) . For early detection of suspected hearing loss, it is the best method, and if the newborn hearing screening is not universal, more than 30% of permanent hearing loss can be missed (Jakubikova et al., 2009 ). Severe to profound hearing loss could reliably be detected by behavioral hearing screening of neonates and was detected in 17 of 17,000 infants. Two screening tests were used. Automated auditory brain stem response which measures average neural response to a large number of repeated sound signals, and measurement of spontaneous or sound induced otoacoustic emissions detects sound produced by movements of outer hair cells of cochlear (Morton et al., 2006) Screening of the GJB2 mutation can be done with high sensitivity and specificity for individuals with congenital deafness, by screening only for the 35delG mutation. A positive finding should make an etiologic diagnosis and affect genetic counselling (Green et al., 1999) . PCR is also widely used as the initial DNA amplification step for genetic testing (Li et al., 2008) . PCR-based sequence analysis has been shown to be an efficient method for identifying pathogenic mutations in this gene with non-syndromic deafness of uncertain etiology (Pandya et al., 2003) . A negative family history does not exclude GJB2 deafness (Pandya et al., 2003) . All PCR products should be sequenced on both strands, thus allowing to detect the normal and the mutated allele in the normal hearing parents and deaf children heterozygous for the 30delG mutation (Denoyelle et al., 1997) . For possible future use, DNA banking, which is the storage of DNA extracted from white blood cells can be done. Genetic forms of hearing loss must be distinguished from non-genetic (acquired) causes of hearing loss. The genetic forms of hearing loss are diagnosed by otologic, audiologic, and physical examination, family history, CT examination of the temporal bone, and molecular genetic testing. Molecular genetic testing, is possible for many types of syndromic and nonsyndromic deafness, and for diagnosis and genetic counseling (Hilgert et al., 2009) . Molecular genetic testing approaches can include a combination of gene-targeted testing (single-gene testing and a multi-gene panel) and genomic testing (comprehensive genomic sequencing) (Smith et al., 2016; www.genetics.edu.au.2016) . Whole-exome sequencing (WES) and whole-genome sequencing (WGS) may be considered if the phenotype alone is insufficient to warrant gene-targeted testing. Both WES and WGS should be complemented with appropriate genetic counseling before and after testing to consider in interpretation of genomic test results (Smith et al., 2016) . As serial gene sequencing approaches are expensive and time consuming some use compresensive genetic diagnostic platform with massively parallel sequencing (Sheearer et al., 2010) Mutations in GJB2 are the most common cause of nonsyndromic autosomal recessive hearing impairment, from mild to profound deafness, and mutation analysis of this gene is widely available as a genetic diagnostic test (Cryns et al., 2004) . Once the GJB2 pathogenic variants have been identified in a family member with DFNB1, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis (Genetic Home Reference. http//ghr.nlm.nih.gov/primer/testing/genetictesting)are possible options, which can be done (Smith et al., 2016) . Tests for mutations in GJB2, GJB3, SLC26A4 and mitochondrial 12S rRNA are now available on a research or clinical basis (Fu et al., 2010) . Screening the GJB2and SLC26A4 genes should form the basis of any genetic testing programme for childhood deafness (Hutchin et al., 2005) .The high prevalence of mutations in GJB2 in some population provides the tools for molecular diagnosis, carrier detection and prenatal diagnosis of congenital hearing impairment (Rabionet et al., 2000) .
With hearing loss for mutations in GJB2 using an allele-specific polymerase chain reaction assay, single-strand conformation polymorphism analysis, and direct sequencing can also be used. But as there are more than 80 genes and more than a thousand reported deafness-causing mutations. This extreme genetic heterogeneity makes genetic diagnosis for Non Syndromic Hearing Loss exceedingly difficult (Shearer et al., 2015) .
Establishing the diagnosis
Family history. A three-generation family history including relatives with hearing loss and associated findings should be obtained (Smith et al., 2014) . In simplex families (only one affected child) (Smith et al., 2002) , allele variants of many genes are known to cause hereditary deafness (Smith et al., 2002) . Children at risk for hereditary hearing loss should undergo molecular genetic testing , and also screening audiometry (Hilgert et al., 2009) . Genetic testing is a family, rather than an individual, matter and that family involvement in the decision making process should be strongly encouraged in order to help families adjust (Sobel et al., 2000) . Clinical examination. All persons with hearing loss of unknown cause should be evaluated for signs and symptoms of syndromic deafness. Important features include branchial cleft pits, cysts or fistulae, high myopia, white forelock, pigmentary retinopathy, telecanthus, preauricular pits, heterochromia iridis, pigmentary anomalies, goiter, and craniofacial anomalies. Serologic tests for toxoplasma (IgM, CMV IgM, Rubella IgM, HSV1 IgM), CT scan, and ophthalmologic evaluation can also be done (Morzaria et al., 2004) . Physiologic tests like auditory brain stem response testing (ABR/ BAER). Auditory steady-state response testing (ASSR), Evoked oto-acoustic emissions (EOAEs), Immittance testing tympanometry, acoustic reflex decay, acoustic reflex thresholds, Audiometry, Behavioral testing, and Audioprofile should be done by persons who specialise in these subjects.
Management
Hereditary hearing loss should be managed by a team with otolaryngologist, audiologist, pediatrician, clinical geneticist, and a neurologist, with educator of the Deaf, and a pediatric ophthalmologist (Hilgert et al., 2009) . Early auditory intervention by amplification, otologic surgery, or cochlear implantation is important and necessary for optimal cognitive development in children with prelingual deafness (Hilgert et al., 2009) . During the past three to four decades, the incidence of acquired sensorineural hearing loss (SNHL) in children living in more developed countries has reduced, because of the immunisation programmes. Thou there is overall decrease there is increase again in the inherited forms of SNHL ( Gorlin et al., 1995; Smith et al., 2005; Marazita et al., 1993) . Cochlear implantation can be considered in children between 12 months ,and 2 years, and it shows better speech perception and language abilities, when compare with those done after that age (Kirk et al., 2000; Svirsky et al., 2004) in severe-to-profound hearing loss.  In 2012 researches detected growth of cochlear nerve cells with hearing improvements in gerbils, by using human embryonic stem cells (Rojahn , 2012) . In 2013 there was also a report, saying there could be regrowth of hair cells in deaf adult mice, using a drug resulting in hearing improvement. A potential cure for permanent deafness has been found by scientists using a drug that stimulates the inner ear, in a study by Harvard Medical School. The drug, codenamed LY411575, can trigger and regenerate the sensory hair cells (www.dailymail.co.uk)  To restore hearing, the Hearing Health Foundation in US had started a project called Hearing Restoration Project and in UK Action on Hearing loss were done.  Genetically deaf mice which were treated with TMC1 gene therapy can recover some of their hearing (Askew et al., 2015) was also reported in 2015. With these numerous research, in the world, there is future and hope for sensorineural hearing loss and deaf mute or deaf people.
Conclusions
It should be noted that there should be a concerted effort in identifying the patients and looking for the itiology, managing, counselling these people early, so as to make and help these people in their life.
